Company Beximco Pharmaceuticals Limited

Equities

BXPHARMA

BD0453BXPH04

Pharmaceuticals

End-of-day quote Dhaka S.E. 06:00:00 2024-04-14 pm EDT 5-day change 1st Jan Change
118.3 BDT -1.09% Intraday chart for Beximco Pharmaceuticals Limited -1.42% -19.08%

Business Summary

Beximco Pharmaceuticals Ltd. is a manufacturer and exporter of medicines in Bangladesh. The Company is engaged in manufacturing and marketing of generic pharmaceuticals formulation products covering a range of therapeutic categories. It offers products in different dosage forms including solid, liquid, cream and ointment, suppositories, metered dose inhaler, dry powder inhaler, nasal spray, sterile, lyophilized injectable and large volume intravenous fluids. It also manufactures active pharmaceutical ingredients (APIs) and renders contract manufacturing services to other companies. It produces different presentations, and the portfolio encompasses all key therapeutic categories, including antibiotics, analgesics, anti-diabetic, respiratory, cardiovascular, central nervous system, dermatology, gastrointestinal and others. The Company's products include Atrizin, Nomos, Azithrocin, Ceftoril, Bemsivir, Viraflu, Viracin, Rilovir, Flurium, Nervalin, Seropam, Nightus, and others.

Number of employees: 5,700

Sales per Business

BDT in Million2022Weight2023Weight Delta
Pharmaceutical Formulations and Active Pharmaceutical Ingredients
100.0 %
34,669 100.0 % 39,267 100.0 % +13.26%

Sales per region

BDT in Million2022Weight2023Weight Delta
Bangladesh
100.0 %
34,669 100.0 % 39,267 100.0 % +13.26%

Managers

Managers TitleAgeSince
Director of Finance/CFO 61 89-12-31
Chief Tech/Sci/R&D Officer - -
Chief Tech/Sci/R&D Officer - -
Chief Operating Officer - 05-02-28
Director/Board Member - -
Corporate Officer/Principal - -
Human Resources Officer - -
Corporate Officer/Principal - -
Comptroller/Controller/Auditor - -
Corporate Officer/Principal - 06-12-31

Members of the board

Members of the board TitleAgeSince
Founder - 75-12-31
Founder - 75-12-31
Chief Executive Officer - 84-12-31
Director/Board Member - 90-12-31
Director/Board Member - 92-12-31
Director/Board Member - -
Director/Board Member - 20-07-29
Director/Board Member 64 20-11-29
Director/Board Member 36 20-11-29
Director/Board Member 64 21-01-17

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 446,112,089 342,099,318 ( 76.68 %) 0 76.68 %

Shareholders

NameEquities%Valuation
New Dacca Industries Ltd.
3.216 %
14,345,757 3.216 % 15 M BDT
Silk Invest Ltd.
0.2869 %
1,279,740 0.2869 % 1 M BDT
DFP Deutsche Finanz Portfolioverwaltung GmbH
0.0524 %
233,951 0.0524 % 244 289 BDT
Walker Crips Asset Managers Ltd.
0.0239 %
106,515 0.0239 % 111 222 BDT
Banor Capital Ltd.
0.007595 %
33,883 0.007595 % 35 380 BDT
Eurizon Capital SA
0.004584 %
20,450 0.004584 % 21 354 BDT
NameEquities%Valuation
Thesis Unit Trust Management Ltd.
0.8413 %
3,753,200 0.8413 % 2 M BDT
Tundra Fonder AB
0.3390 %
1,512,500 0.3390 % 745 163 BDT
eQ Varainhoito Oy
0.0828 %
369,467 0.0828 % 182 025 BDT
Renta 4 Gestora SGIIC SA
0.0425 %
189,456 0.0425 % 93 339 BDT
LRI Capital Management SA
0.0336 %
150,000 0.0336 % 73 901 BDT
Caravan Capital Management LLC
0.0202 %
90,200 0.0202 % 44 439 BDT
Swedbank Robur Fonder AB
0.000197 %
878 0.000197 % 433 BDT

Company contact information

Beximco Pharmaceuticals Ltd.

19 Dhanmondi R/A Road No. 7

1205, Dhaka

+880 2 5861 1001

http://www.beximcopharma.com
address Beximco Pharmaceuticals Limited(BXPHARMA)
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
2
Last Close Price
118.3 BDT
Average target price
153.5 BDT
Spread / Average Target
+29.75%
Consensus

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. BXPHARMA Stock
  4. Company Beximco Pharmaceuticals Limited